Oramed Pharmaceuticals
ORMP
#9228
Rank
ยฃ0.12 B
Marketcap
ยฃ2.97
Share price
-0.75%
Change (1 day)
71.81%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): ยฃ46.64 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of ยฃ46.63 Million, an increase over its 2024 earnings that were of -ยฃ11.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ46.64 M0.03%
2025 ยฃ46.63 M-513.21%
2024 -ยฃ11.29 Million-311.47%
2023 ยฃ5.33 M-119.45%
2022 -ยฃ27.44 Million39.17%
2021 -ยฃ19.72 Million73.93%
2020 -ยฃ11.34 Million18.53%
2019 -ยฃ9.57 Million-16.62%
2018 -ยฃ11.47 Million38.32%
2017 -ยฃ8.3 Million12.51%
2016 -ยฃ7.37 Million25.01%
2015 -ยฃ5.9 Million18.18%
2014 -ยฃ4.99 Million39.72%
2013 -ยฃ3.58 Million46.4%
2012 -ยฃ2.44 Million128.32%
2011 -ยฃ1.07 Million-51.47%
2010 -ยฃ2.21 Million35.21%
2009 -ยฃ1.63 Million
2007 -ยฃ2.56 Million607.04%
2006 -ยฃ0.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
ยฃ17.21 B 36,485.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.83 B 12,296.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.34 Billion-811.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ45.79 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ26.12 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel